A Q3 2021 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q3 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.6B+25.8% YoY

Gross Profit

$852M53.7% margin

Operating Income

$336M21.2% margin

Net Income

$264M16.6% margin

EPS (Diluted)

$0.86

QoQ Revenue Growth

+4.0%

Cash Flow

Operating Cash Flow

$334M

Free Cash Flow

$279M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$10.5B

Total Liabilities

$5.5B

Stockholders' Equity

$4.9B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.3B	+25.8%
Gross Profit	$852M	$669M	+27.4%
Operating Income	$336M	$230M	+46.1%
Net Income	$264M	$199M	+32.7%

Revenue Segments

Life Sciences and Applied Markets

$680M43%

Agilent CrossLab

$560M35%

Diagnostics and Genomics

$346M22%

Geographic Segments

Americas

$606M38%

Asia Pacific

$557M35%

Europe

$423M27%